Related Experiment Video

Updated: Aug 19, 2026

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

Mechanism of action of T-705 against influenza virus

Yousuke Furuta1, Kazumi Takahashi, Masako Kuno-Maekawa

  • 1Research Laboratories, Toyama Chemical Co., Ltd., 2-4-1 Shimookui, Toyama 930-8508, Japan. YOUSUKE_FURUTA@toyama-chemical.co.jp

Antimicrobial Agents and Chemotherapy
|February 25, 2005
PubMed

Insights

T-705 demonstrates potent anti-influenza activity by inhibiting viral RNA polymerase. This compound, T-705-triphosphate, selectively targets influenza replication without affecting host cell synthesis, suggesting reduced cytotoxicity.

Area of Science:

  • Virology
  • Antiviral Drug Development
  • Molecular Biology

Background:

  • Influenza virus poses a significant global health threat.
  • Development of novel antiviral agents with improved specificity and reduced toxicity is crucial.
  • T-705 (favipiravir) is a substituted pyrazine derivative with known antiviral properties.

Purpose of the Study:

  • To elucidate the mechanism of action of T-705 against influenza virus.
  • To investigate the specific molecular targets and cellular pathways affected by T-705.
  • To compare the antiviral activity and cytotoxicity profile of T-705 with ribavirin.

Main Methods:

  • Time-of-addition studies to determine the stage of viral replication targeted by T-705.
  • Assessment of T-705 activity in the presence of purines and pyrimidines.
  • Detection and characterization of T-705 metabolites (T-705RTP, T-705RMP) in treated cells.
  • In vitro assays to evaluate the inhibitory effect of T-705RTP on influenza virus RNA polymerase.
  • Analysis of T-705's impact on cellular DNA and RNA synthesis.
  • Comparison of T-705RMP's inhibitory effect on IMP dehydrogenase with ribavirin monophosphate.

Main Results:

  • T-705 inhibits an early to middle stage of influenza viral replication, not adsorption or release.
  • T-705 activity is dependent on purine availability and is attenuated by purines/purine nucleosides.
  • T-705 is converted intracellularly to T-705RTP and T-705RMP.
  • T-705RTP acts as a dose-dependent, GTP-competitive inhibitor of influenza virus RNA polymerase.
  • T-705 does not affect cellular DNA or RNA synthesis, unlike ribavirin.
  • T-705RMP exhibits significantly weaker inhibition of IMP dehydrogenase compared to ribavirin monophosphate.

Conclusions:

  • T-705 exhibits selective anti-influenza virus activity through the inhibition of viral RNA polymerase by its active metabolite, T-705RTP.
  • The compound's mechanism of action and reduced impact on host cell nucleic acid synthesis suggest a favorable safety profile.
  • T-705 represents a promising antiviral agent for influenza treatment with potentially lower cytotoxicity than existing therapies.

More Related Videos

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity07:15

Preparation of Pseudo-Typed H5 Avian Influenza Viruses with Calcium Phosphate Transfection Method and Measurement of Antibody Neutralizing Activity

Published on: November 22, 2021

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice07:07

Evaluation of T Follicular Helper Cells and Germinal Center Response During Influenza A Virus Infection in Mice

Published on: June 27, 2020

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...